FDA recently granted emergency use authorization (EUA) to Gilead for the investigational antiviral, remdesivir, to treat COVID-19 patients.
For more coronavirus updates, visit our resource...
FDA recently approved the first treatment for pediatric patients with neurofibromatosis phase 1 (NF1), a rare disease that affects children.
NF1 is a rare, progressive condition of the nervous...
Sanofi and GSK recently announced that they signed a letter of intent to develop an adjuvanted COVID-19 vaccine.
For more coronavirus updates, visit our resource page, updated twice daily...
Repurposed generics show promise as potential COVID-19 drugs and may be manufactured profitably at very low costs, according to a recent study.
For more coronavirus updates, visit...
A recent study found that 68 percent of COVID-19 patients who received compassionate-use remdesivir showed clinical improvement, but measurements of efficacy will require ongoing controlled trials to...
A clinical trial to evaluate the safety and efficacy of hydroxychloroquine for the treatment of hospitalized adult COVID-19 patients has begun, according to a recent press release from the National...
The Pfizer Foundation recently announced the commitment of $40 million in medical and charitable cash grants to help combat the global health effects of the COVID-19 pandemic.
For more...
Henry Ford Health System will lead the first large-scale study in the US to determine the effectiveness of hydroxychloroquine in preventing COVID-19 among healthcare workers and first...
The US currently has the most coronavirus cases of any country, with more than 330,000 individuals diagnosed with the virus, according to the CDC . Those are just the known cases, but experts...
As the number of confirmed COVID-19 cases continues to grow, pharmaceutical companies are boosting their efforts to combat the virus. There are currently over 245,000 cases of coronavirus in the US, a...
Genome-sequencing software NVIDIA announced that it will provide a free 90-day license to Parabricks to any researcher worldwide for rapid COVID-19 sequencing, according to a recent press...
Hospitalized adult patients with confirmed COVID-19, experienced no benefits in lopinavir- ritonavir treatment compared to standard care, according to a recent clinical trial, LOTUS China...
The Bill and Melinda Gates Foundation, Wellcome, and Mastercard recently launched an initiative to boost drug discovery and biologics to treat patients with COVID-19.
For more coronavirus updates,...
The US Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) issued warning letters to seven companies for selling false coronavirus (COVID-19) drugs, vaccines, and other products,...
As the FDA closely monitors the coronavirus supply chain, it has uncovered a drug shortage related to a site affected by the coronavirus, or COVID-19, according to a recent statement from Stephen M....
Remdesivir is effective in treating Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS), but also may be a successful drug for patients with coronavirus, or COVID-19,...
Janssen Pharmaceutical Companies will expand its partnership with Department of Health and Human Services (HHS) to accelerate a vaccination discovery for the coronavirus or COVID-19, Johnson &...
US Food and Drug Administration (FDA) recently issued six final guidances and draft guidance to advance gene therapy development by clarifying the policy framework for development and...
The pharmaceutical industry is inching closer to the $1.3 trillion mark, with future growth anticipated for life sciences companies worldwide.
According to the IQVIA Institute, the global...
Clinical trial research outcomes need to be more patient-centered and integrate more patient-reported outcomes, according to a new set of research principles designed by the American College of...
